ResearcherKyoto UniversityActive in the last 2 years
Toshihiro Morita
Matched on ORCID iD 0000-0002-4114-9894; OpenAlex author ID A5009442700. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/cancers18071177↗
- Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. Co-author DOI 10.1038/s41416-024-02794-5↗
- Correction: CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-21-1255↗
- CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-19-2745↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroshi Seno · 4 shared papers, 2020–2026 · strength 0.53
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177↗
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Paper Correction: CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-21-1255↗
- Kosuke Minaga · 2 shared papers, 2024–2026 · strength 0.34
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177↗
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Munenori Kawai · 2 shared papers, 2024–2026 · strength 0.34
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177↗
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Atsushi Umemura · 2 shared papers, 2024–2026 · strength 0.34
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177↗
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Shujiro Yazumi · 2 shared papers, 2024–2026 · strength 0.34
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177↗
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Akihisa Fukuda · 2 shared papers, 2024–2026 · strength 0.34
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177↗
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Takahisa Maruno · 3 shared papers, 2020–2024 · strength 0.32
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Paper Correction: CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-21-1255↗
- Paper CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-19-2745↗
- Kazuyuki Nagai · 1 shared paper, 2026 · strength 0.21
- Etsuro Hatano · 1 shared paper, 2026 · strength 0.21
- Hirotaka Kashima · 1 shared paper, 2026 · strength 0.21
- Kei Iimori · 1 shared paper, 2026 · strength 0.21
- Tsutomu Chiba · 2 shared papers, 2020–2021 · strength 0.18
- Yoshihiro Nishikawa · 2 shared papers, 2020–2021 · strength 0.18
- Tomoaki Matsumori · 2 shared papers, 2020–2021 · strength 0.18
- Motoyuki Tsuda · 2 shared papers, 2020–2021 · strength 0.18
- Yuzo Kodama · 2 shared papers, 2020–2021 · strength 0.18
- Toshinao Itani · 1 shared paper, 2024 · strength 0.13
- Kozo Ikuta · 1 shared paper, 2024 · strength 0.13
- Nobuhiro Hieda · 1 shared paper, 2024 · strength 0.13
- Yukitaka Yamashita · 1 shared paper, 2024 · strength 0.13
- Makoto Sono · 1 shared paper, 2024 · strength 0.13
- Masaya Ohana · 1 shared paper, 2024 · strength 0.13
- Masatoshi Kudo · 1 shared paper, 2024 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.